T

Tenaya Therapeutics

136 employees

Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.

Basic info

Industry

biotechnology research

Sectors

Cardiovascular Disease
Biotechnology
iPSC-Cardiomyoctyes
Gene Therapy
Health Care
Therapeutics
Heart Failure
Cardiomyopathies
Biopharma
Cellular Regeneration
In Vivo Cellular Reprogramming
Precision Medicine

Date founded

2016

Funding rounds raised

Total raised

$106M

from 11 investors over 11 rounds

T

Tenaya Therapeutics raised $106M on March 1, 2021

Investors: Casdin Capital, LLC, RA Capital Management, L.P., GV, The Column Group, RTW Investments, LP and T. Rowe Price

T

Tenaya Therapeutics raised $92M on October 3, 2019

Investors: Greenspring Associates, Casdin Capital, LLC, GV and The Column Group

T

Tenaya Therapeutics raised $50M on December 6, 2016

Investors: The Column Group

FAQ